In vitro cross-reactivity. Cryopreserved PBMC of five
HCV-seronegative, healthy controls were stimulated for 3 weeks in vitro
in the presence of IL-2, IL-7, IL-12, and 10 μg of
IVNA-231, HPVL1-315, or WAG61
peptide per ml. Each CTL line was tested in a 6-h
51Cr release assay against C1R-A2 targets pulsed overnight
with 10 μg of HCVNS3-1073 (▪), IVNA-231
(▨), HPVL1-315 (░⃞), or WAG161 (□) per ml.
The 10% cutoff for a positive CTL assay is indicated by the horizontal
line.